Top Page
Iperionx Limited
(Sydney:IPX)
Iperionx Limited (IPX) vs. iShares MSCI Australia ETF (EWA)
Iperionx Limited Business Overview & Revenue Model
Iperionx Limited Financial Statement Overview
| Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | ― | -634.11K | -211.58K | ― | ― |
| EBITDA | ― | -22.49M | -25.62M | -29.39M | -13.30M | ― |
| Net Income | -27.59M | -22.23M | -25.93M | -21.52M | ― | ― |
Balance Sheet | ||||||
| Total Assets | 115.83M | 55.44M | 34.26M | 9.91M | 3.72M | ― |
| Cash, Cash Equivalents and Short-Term Investments | 77.13M | 33.16M | 17.93M | 5.67M | 1.70M | ― |
| Total Debt | 4.19M | 1.49M | 1.47M | 543.03K | 475.65K | ― |
| Total Liabilities | 10.29M | 4.10M | 3.37M | 2.49M | 762.50K | ― |
| Stockholders Equity | 105.54M | 51.34M | 30.89M | 7.42M | 1.76M | ― |
Cash Flow | ||||||
| Free Cash Flow | -2.83M | -26.68M | -18.57M | -14.06M | -3.62M | ― |
| Operating Cash Flow | ― | -18.61M | -15.86M | -12.13M | -3.56M | ― |
| Investing Cash Flow | -5.61M | -6.53M | -5.71M | -3.07M | 1.76M | ― |
| Financing Cash Flow | 29.09M | 46.59M | 27.89M | 19.39M | 3.50M | ― |
Iperionx Limited Technical Analysis
Iperionx Limited Risk Analysis
Iperionx Limited Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $9.95B | 9.44 | -0.15% | 2.99% | 1.92% | -35.27% | |
38 Underperform | AU$1.52B | ― | -38.95% | ― | ― | -16.77% | |
| $177.01M | ― | -33.63% | ― | ― | ― | ||
| $2.89B | 22.94 | -1.04% | ― | ― | ― | ||
| $5.43B | 162.29 | 2.27% | ― | ― | ― | ||
| $1.08B | 6.13 | 10.39% | 1.98% | ― | ― | ||
| $2.70B | 43.31 | -33.95% | 4.54% | ― | ― |
Iperionx Limited Corporate Events
IperionX Limited has made significant strides in its titanium manufacturing operations, with the commissioning of its Titanium Manufacturing Campus in Virginia progressing rapidly. The company is on track to achieve full operational capacity by mid-2025, supported by advancements in its proprietary HAMR and HSPT technologies. IperionX has secured substantial funding from the U.S. Department of Defense and the U.S. Export-Import Bank, which will facilitate the expansion of its titanium production capacity. Additionally, the company is actively engaging with strategic partners across various industries, including defense and aerospace, to accelerate the market introduction of its high-performance titanium components.
IperionX Limited has received approval from the Export-Import Bank of the United States for an $11 million loan to enhance its titanium manufacturing capabilities. The loan will finance the acquisition of advanced manufacturing equipment, supporting the company’s mission to establish a fully integrated, end-to-end titanium supply chain within the U.S. This initiative aligns with national objectives to strengthen domestic manufacturing and reduce reliance on foreign titanium sources, addressing economic and national security vulnerabilities. The expansion is expected to create skilled manufacturing jobs in Virginia and bolster IperionX’s position in the titanium industry.
Iperionx Limited has announced that Vanguard Group, a prominent investment management company, has become a substantial holder in the company as of March 21, 2025. Vanguard Group now holds a 5.017% voting power in Iperionx Limited, which could influence the company’s strategic decisions and potentially impact its market positioning.
Iperionx Limited has announced the appointment of R. Tony Tripeny as a director, effective March 17, 2025. This appointment includes an allocation of 42,486 restricted stock units expiring in December 2028, indicating a strategic move to strengthen the company’s leadership and potentially enhance its market position.
IperionX Limited has announced the issuance of 3,314,762 fully paid ordinary shares, which are part of a class of securities quoted on the Australian Securities Exchange. This issuance was conducted without disclosure to investors under Part 6D.2 of the Corporations Act 2001, and the company has confirmed compliance with relevant legal provisions, indicating transparency and adherence to regulatory requirements.
IperionX Limited announced a change in the director’s interest, specifically involving Todd Hannigan. The change includes the conversion of 159,333 restricted stock units into shares and an off-market transfer of 3,891,429 shares to UBS Securities Australia Limited as part of a loan facility. This adjustment reflects a strategic financial maneuver, allowing DITM Holdings Pty Ltd, as trustee for The DITM Family Trust, to leverage shares as security for an 18-month loan, indicating a tactical approach to capital management.
Iperionx Limited has announced the quotation of 3,163,002 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of March 14, 2025. This move is part of the company’s strategy to enhance its financial flexibility and strengthen its market position, potentially impacting its operational capabilities and offering new opportunities for stakeholders.
Iperionx Limited announced the issuance of 151,760 ordinary fully paid shares to consultants as a form of compensation for their services. This move is part of the company’s strategy to leverage expertise and enhance its operational capabilities, potentially strengthening its position within the advanced materials industry.
Iperionx Limited has released its interim financial report for the six months ended December 31, 2024. The report includes various financial statements and declarations, providing insights into the company’s financial position and performance over the period. This release is crucial for stakeholders to assess the company’s operational health and make informed decisions.
IperionX Limited has strengthened its Board of Directors with the appointment of Tony Tripeny as a Non-Executive Director and Lorraine Martin as the Lead Independent Director. Tony Tripeny brings over 40 years of experience in financial and operational leadership from his tenure at Corning Incorporated, while Lorraine Martin offers extensive leadership experience in the aerospace and defense industries. These appointments are expected to enhance IperionX’s leadership in the titanium and advanced manufacturing sectors, contributing to the company’s growth and strategic positioning.
Iperionx Limited has announced significant progress with the development of their Virginia Titanium Campus, which aims to transform titanium production. The company is addressing the inefficiencies of traditional titanium production methods, like the Kroll process, by pioneering new technologies that could significantly reduce costs and energy consumption. This breakthrough could potentially lead to industry-wide changes, comparable to historical transformations in steel and aluminum production, which made them more affordable and widely used. Iperionx’s approach involves creating fully-integrated supply chains to enhance efficiency and reduce costs, potentially positioning them as a leader in the titanium market.